Taysha Gene Therapies, Inc.(TSHA)
$4.37▲0.06 (1.39%)
Taysha Gene Therapies, Inc.(TSHA)
NASDAQ
$4.37▲0.06 (1.39%)
Trailing Twelve Months (TTM) Metrics
Per Share (TTM)
Revenue/Share$0.03
Net Income/Share$-0.34
Operating CF/Share$-0.29
Free CF/Share$-0.29
Cash/Share$1.00
Book Value/Share$0.77
Tangible Book/Share$0.77
Equity/Share$0.77
Interest Debt/Share$0.06
CapEx/Share$0.00
Dividend/Share$0.00
Valuation
Market Cap$952.00M
Enterprise Value$650.41M
P/E Ratio-12.82P/S Ratio97.41P/OCF Ratio-15.01
P/FCF Ratio-10.15
P/B Ratio5.66P/TB Ratio5.66
EV/Sales66.55EV/EBITDA-6.01
Graham Valuation
Graham Number--
Graham Net-Net$0.70
Profitability
Earnings Yield-7.80%FCF Yield-9.86%ROE-56.64%ROIC-34.88%Return on Tangible Assets-31.75%Dividend
Dividend Yield0.00%Payout Ratio0.00%Capital Allocation
CapEx/OCF-0.79%
CapEx/Revenue7.55%
CapEx/Depreciation0.57
SBC/Revenue136.07%
SG&A/Revenue346.55%
R&D/Revenue878.11%
Liquidity & Solvency
Debt/Equity0.07Debt/Assets0.05Debt/Market Cap0.02
Net Debt/EBITDA2.79
Current Ratio12.23Interest Coverage-1753.94xIncome Quality0.85Efficiency
Days Sales Outstanding0 days
Days Payables Outstanding3915 days
Days Inventory0 days
Receivables Turnover0.00x
Payables Turnover0.09x
Inventory Turnover0.00x
Capital Structure
Tangible Assets$246.94M
Working Capital$298.10M
Invested Capital$314.27M
Intangibles/Assets0.00%